Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2013; 19(20): 3083-3089
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3083
Published online May 28, 2013. doi: 10.3748/wjg.v19.i20.3083
Table 1 Patient demographics
| HIFU (n = 10) | TACE (n = 29) | P value | |
| Age (yr) | 59.5 (49-76) | 57 (43-65) | 0.107 |
| Sex (male/female) | 7/3 | 24/5 | 0.399 |
| Child-Pugh A disease | 3 (30) | 17 (58.6) | 0.267 |
| Child-Pugh B disease | 6 (60) | 12 (41.4) | |
| Child-Pugh C disease | 1 (10) | 0 | |
| Carrier of hepatitis B virus | 5 (50) | 28 (96.5) | 0.002 |
| Carrier of hepatitis C virus | 4 (40) | 1 (3.4) | 0.011 |
| Serum bilirubin (μmol/L) | 14.5 (6-36) | 25 (4-49) | 0.074 |
| Serum albumin (g/dL) | 32 (27-38) | 34 (20-43) | 0.606 |
| Platelet count (109/L) | 67 (28-166) | 59 (23-144) | 0.688 |
| Aspartate transaminase (U/L) | 52 (29-141) | 47 (15-104) | 0.440 |
| Alanine transaminase (U/L) | 44 (26-109) | 36 (9-132) | 0.376 |
| Alpha-fetoprotein (ng/mL) | 8 (2-160) | 24 (1-1151) | 0.101 |
| International normalized ratio | 1.25 (0.9-1.5) | 1.3 (1.0-1.5) | 0.960 |
| Largest tumor size (cm) | 2.6 (1.2-4.0) | 2.0 (0.8-4.3) | 0.252 |
| Tumor number | 1 (1-2) | 1 (1-3) | 0.172 |
- Citation: Cheung TT, Fan ST, Chan SC, Chok KS, Chu FS, Jenkins CR, Lo RC, Fung JY, Chan AC, Sharr WW, Tsang SH, Dai WC, Poon RT, Lo CM. High-intensity focused ultrasound ablation: An effective bridging therapy for hepatocellular carcinoma patients. World J Gastroenterol 2013; 19(20): 3083-3089
- URL: https://www.wjgnet.com/1007-9327/full/v19/i20/3083.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i20.3083